REV-MED participated in the 38th Korea International Medical & Hospital Equipment Show (KIMES 2023), unveiling its diverse range of medical devices, including bio-kits and laser-based therapy systems.
Held at COEX in Seoul from March 23–26, KIMES 2023 featured four exhibition zones:
- Treatment and Medical Information Zone (Hall A)
- Healthcare and Rehabilitation Equipment Zone (Halls B, D, and Grand Ballroom)
- Inspection and Diagnostic Equipment Zone (Hall C)
- Diagnostics and Hospital Equipment Zone (Hall D)
In the Grand Ballroom Hall, REV-MED captured attention with its innovative cell regeneration therapy systems utilizing autologous stem cells and laser medical devices for pain relief.
CEO Edward BG Shin stated, “At this exhibition, we are showcasing bio-kits designed for the U.S. market and upgraded versions tailored for dermatology applications. REV-MED will continue to identify user needs and enhance our products to expand and penetrate new markets.”
This strategic focus on addressing global market demands demonstrates REV-MED's commitment to leading advancements in autologous stem cell therapy and medical device innovation.
Source : HealthTrends (http://www.k-health.com)
REV-MED participated in the 38th Korea International Medical & Hospital Equipment Show (KIMES 2023), unveiling its diverse range of medical devices, including bio-kits and laser-based therapy systems.
Held at COEX in Seoul from March 23–26, KIMES 2023 featured four exhibition zones:
In the Grand Ballroom Hall, REV-MED captured attention with its innovative cell regeneration therapy systems utilizing autologous stem cells and laser medical devices for pain relief.
CEO Edward BG Shin stated, “At this exhibition, we are showcasing bio-kits designed for the U.S. market and upgraded versions tailored for dermatology applications. REV-MED will continue to identify user needs and enhance our products to expand and penetrate new markets.”
This strategic focus on addressing global market demands demonstrates REV-MED's commitment to leading advancements in autologous stem cell therapy and medical device innovation.
Source : HealthTrends (http://www.k-health.com)